Relationship of adiponectin levels with the severity of chronic obstructive pulmonary disease
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Accepted: 4 May 2025
Authors
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and tissue damage. Adipose tissue has been identified as a contributing factor to systemic inflammation in COPD. Adiponectin is present in the airway epithelial cells and bronchoalveolar lavage fluid of patients with COPD. This suggests that adiponectin and COPD patients are related. This study aims to determine the relationship between adiponectin levels and the severity of COPD. Patients with COPD who are registered at Hasanuddin University Hospital and who fit the study’s criteria served as the subjects of this cross-sectional study. The patients who had other chronic conditions were excluded. Every patient had their adiponectin levels measured. Based on the ABE group, the severity of COPD was evaluated. Version 29.0 of SPSS was used. A total of 88 subjects were included, with 12 (13.6%) women and 76 (86.4%) men. The mean age was 64.29±9.50 years. The mean adiponectin level was 33.57±14.61. Adiponectin levels were significantly correlated with the severity of COPD (p=0.001). In conclusion, the severity of COPD decreases with increasing adiponectin levels.
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.